The University of Chicago Header Logo

Connection

Tamar S. Polonsky to Peripheral Arterial Disease

This is a "connection" page, showing publications Tamar S. Polonsky has written about Peripheral Arterial Disease.
  1. Discordance of patient-reported outcome measures with objectively assessed walking decline in peripheral artery disease. J Vasc Surg. 2024 Apr; 79(4):893-903.
    View in: PubMed
    Score: 0.875
  2. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy. J Am Heart Assoc. 2021 06 15; 10(12):e017609.
    View in: PubMed
    Score: 0.734
  3. Lower Extremity Peripheral Artery Disease Without Chronic Limb-Threatening Ischemia: A Review. JAMA. 2021 Jun 01; 325(21):2188-2198.
    View in: PubMed
    Score: 0.734
  4. Associations of Weight Change With Changes in Calf Muscle Characteristics and Functional Decline in Peripheral Artery Disease. J Am Heart Assoc. 2019 07 02; 8(13):e010890.
    View in: PubMed
    Score: 0.642
  5. Durability of Benefits From Supervised Treadmill Exercise in People With Peripheral Artery Disease. J Am Heart Assoc. 2019 01 08; 8(1):e009380.
    View in: PubMed
    Score: 0.622
  6. Home-Based Exercise: A Therapeutic Option for Peripheral Artery Disease. Circulation. 2016 10 18; 134(16):1127-1129.
    View in: PubMed
    Score: 0.533
  7. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: prevalence and associated clinical characteristics. Atherosclerosis. 2014 Nov; 237(1):169-76.
    View in: PubMed
    Score: 0.460
  8. Home-Based Walking Exercise and Supervised Treadmill Exercise in Patients With Peripheral Artery Disease: An Individual Participant Data Meta-Analysis. JAMA Netw Open. 2023 09 05; 6(9):e2334590.
    View in: PubMed
    Score: 0.215
  9. Study Design, Rationale, and Methodology for Promote Weight Loss in Patients With Peripheral Artery Disease Who Also Have Obesity: The PROVE Trial. J Am Heart Assoc. 2023 09 05; 12(17):e031182.
    View in: PubMed
    Score: 0.214
  10. Hospitalizations during home-based walking exercise interventions in peripheral artery disease: Results from two randomized clinical trials. Vasc Med. 2023 Dec; 28(6):583-585.
    View in: PubMed
    Score: 0.214
  11. Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study. Vasc Med. 2023 04; 28(2):122-130.
    View in: PubMed
    Score: 0.208
  12. Medical therapies, comorbid conditions, and functional performance in people with peripheral artery disease enrolled in clinical trials between 2004 and 2021. Vasc Med. 2023 04; 28(2):144-146.
    View in: PubMed
    Score: 0.205
  13. Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial. JAMA. 2022 10 04; 328(13):1315-1325.
    View in: PubMed
    Score: 0.201
  14. Barriers to participation in supervised exercise therapy reported by people with peripheral artery disease. J Vasc Surg. 2023 Feb; 77(2):506-514.
    View in: PubMed
    Score: 0.201
  15. Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial. J Am Heart Assoc. 2022 08 02; 11(15):e025063.
    View in: PubMed
    Score: 0.199
  16. Sustained physical activity in peripheral artery disease: Associations with disease severity, functional performance, health-related quality of life, and subsequent serious adverse events in the LITE randomized clinical trial. Vasc Med. 2021 10; 26(5):497-506.
    View in: PubMed
    Score: 0.182
  17. Effect of Low-Intensity vs High-Intensity Home-Based Walking Exercise on Walk Distance in Patients With Peripheral Artery Disease: The LITE Randomized Clinical Trial. JAMA. 2021 04 06; 325(13):1266-1276.
    View in: PubMed
    Score: 0.182
  18. Associations of Poly (ADP-Ribose) Polymerase1 abundance in calf skeletal muscle with walking performance in peripheral artery disease. Exp Gerontol. 2020 10 15; 140:111048.
    View in: PubMed
    Score: 0.173
  19. Clinical characteristics and response to supervised exercise therapy of people with lower extremity peripheral artery disease. J Vasc Surg. 2021 02; 73(2):608-625.
    View in: PubMed
    Score: 0.171
  20. Association of six-minute walk distance with subsequent lower extremity events in peripheral artery disease. Vasc Med. 2020 08; 25(4):319-327.
    View in: PubMed
    Score: 0.170
  21. Meaningful change in 6-minute walk in people with peripheral artery disease. J Vasc Surg. 2021 01; 73(1):267-276.e1.
    View in: PubMed
    Score: 0.170
  22. Associations of Peripheral Artery Disease With Calf Skeletal Muscle Mitochondrial DNA Heteroplasmy. J Am Heart Assoc. 2020 04 07; 9(7):e015197.
    View in: PubMed
    Score: 0.169
  23. Cocoa to Improve Walking Performance in Older People With Peripheral Artery Disease: The COCOA-PAD Pilot Randomized Clinical Trial. Circ Res. 2020 02 28; 126(5):589-599.
    View in: PubMed
    Score: 0.168
  24. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease. J Vasc Surg. 2020 03; 71(3):988-1001.
    View in: PubMed
    Score: 0.166
  25. Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. J Am Heart Assoc. 2019 01 22; 8(2):e011001.
    View in: PubMed
    Score: 0.156
  26. Peripheral artery disease, calf skeletal muscle mitochondrial DNA copy number, and functional performance. Vasc Med. 2018 08; 23(4):340-348.
    View in: PubMed
    Score: 0.148
  27. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial. JAMA. 2018 04 24; 319(16):1665-1676.
    View in: PubMed
    Score: 0.148
  28. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial. JAMA. 2017 12 05; 318(21):2089-2098.
    View in: PubMed
    Score: 0.144
  29. Femoral artery plaque characteristics, lower extremity collaterals, and mobility loss in peripheral artery disease. Vasc Med. 2017 12; 22(6):473-481.
    View in: PubMed
    Score: 0.142
  30. Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial. JAMA Cardiol. 2017 08 01; 2(8):902-907.
    View in: PubMed
    Score: 0.141
  31. Racial differences in functional decline in peripheral artery disease and associations with socioeconomic status and education. J Vasc Surg. 2017 09; 66(3):826-834.
    View in: PubMed
    Score: 0.138
  32. Association of Cardiovascular Health With Subclinical Disease and Incident Events: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Mar 20; 6(3).
    View in: PubMed
    Score: 0.137
  33. Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events. JACC Cardiovasc Imaging. 2017 09; 10(9):1003-1012.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.